# ENBUMYST
> **NDA219500** · New Drug Application · Sponsor: CORSTASIS THERAP · Approved 2025-09-12
## Drug
- **FDA Application Number:** NDA219500
- **Application type:** New Drug Application
- **Brand name:** ENBUMYST
- **Generic name:** BUMETANIDE
- **Active ingredients:** BUMETANIDE
- **Dosage form:** SPRAY
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** CORSTASIS THERAP
- **Manufacturer:** Corstasis USA LLC
- **First approval:** 2025-09-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219500)
---
*MORVS · CC0 1.0*